Enhatch

10/17/2025

is making serious moves in , and the data backs it up!

❇️ In total knee arthroplasty (TKA), one study with 60 patients compared AI-based 3D planning with traditional 2D X-ray methods.

The AI group saw significantly higher accuracy in predicting prosthesis size, valgus correction angle, and hip-knee-ankle alignment.

❇️ In spine surgery, a study on 208 pedicle screw placements found that AI-assisted planning achieved 85.1% Grade A (no cortical breach) accuracy, compared to just 64.9% with freehand placement.

❇️ In total hip arthroplasty (THA), AI consistently outperformed traditional 2D templating in prosthesis size prediction.

The future of orthopedics is here, and it's powered by AI.



Link to the study in the comment section.

10/15/2025

The demand for patient-specific knees is growing!

The global knee implants market reached $12.18B in 2025, with a projected CAGR of 4.7% through 2029. (GII report)

With the growth in the overall knee market, the demand for increased personalization also grows.

Patient-specific knees are becoming a key driver in the shift toward more precise, tailored care.

To meet this demand at scale, we need smarter, more efficient solutions.

Enhatch’s 3D planning solution for knees makes this possible by streamlining the delivery of patient-specific solutions.

Our solution can deliver detailed 3D models from even X-rays, with powerful segmentation capabilities that accelerate preoperative planning.

Scalable personalization starts here!

10/09/2025

3D printing is moving fast in orthopedics.

It’s not only about design freedom but also the advanced materials powering it.

Magazine | OMTEC Expo highlighted in a recent article that options like , , and are driving innovation by expanding what implants can do and how they interact with the body.

Bioceramics like hydroxyapatite and tricalcium phosphate bring stability, bone-forming properties, and resorbability, allowing bone to gradually replace the implant.

Tantalum is also gaining attention for its role in load-bearing designs, while resorbable polymers continue to push possibilities forward.

For companies building patient-specific solutions, these advancements create new possibilities to design implants that can potentially integrate more naturally with the body.

Which of these materials do you think will shape the next wave of orthopedic innovation?

Link to BONEZONE's article 👉 https://bit.ly/4mTSnZe

Bioceramics, tantalum and resorbable polymers are keys to unlocking new possibilities in 3D printing and orthopedic implant design.

10/02/2025

Seamless integration is critical for any software in .

If a platform doesn’t fit smoothly into your existing systems, it can create more work instead of saving time.

As Mike Phipps, our President and Co-founder, explains:

"𝘛𝘩𝘦 𝘣𝘦𝘴𝘵 3𝘋 𝘱𝘭𝘢𝘯𝘯𝘪𝘯𝘨 𝘴𝘰𝘭𝘶𝘵𝘪𝘰𝘯𝘴 𝘢𝘥𝘢𝘱𝘵 𝘵𝘰 𝘺𝘰𝘶𝘳 𝘦𝘹𝘪𝘴𝘵𝘪𝘯𝘨 𝘱𝘳𝘰𝘤𝘦𝘴𝘴𝘦𝘴 𝘢𝘯𝘥 𝘵𝘦𝘢𝘮 𝘴𝘵𝘳𝘶𝘤𝘵𝘶𝘳𝘦𝘴 𝘳𝘢𝘵𝘩𝘦𝘳 𝘵𝘩𝘢𝘯 𝘧𝘰𝘳𝘤𝘪𝘯𝘨 𝘺𝘰𝘶 𝘵𝘰 𝘤𝘩𝘢𝘯𝘨𝘦 𝘦𝘷𝘦𝘳𝘺𝘵𝘩𝘪𝘯𝘨. 𝘔𝘰𝘥𝘦𝘳𝘯 3𝘋 𝘱𝘭𝘢𝘯𝘯𝘪𝘯𝘨 𝘱𝘭𝘢𝘵𝘧𝘰𝘳𝘮𝘴 𝘢𝘳𝘦 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘦𝘥 𝘸𝘪𝘵𝘩 𝘧𝘭𝘦𝘹𝘪𝘣𝘪𝘭𝘪𝘵𝘺 𝘪𝘯 𝘮𝘪𝘯𝘥, 𝘢𝘤𝘬𝘯𝘰𝘸𝘭𝘦𝘥𝘨𝘪𝘯𝘨 𝘵𝘩𝘢𝘵 𝘦𝘷𝘦𝘳𝘺 𝘵𝘦𝘢𝘮 𝘸𝘰𝘳𝘬𝘴 𝘥𝘪𝘧𝘧𝘦𝘳𝘦𝘯𝘵𝘭𝘺."

At Enhatch, we build 3D planning tools that work the way your teams already do, making collaboration easier and patient-specific planning more efficient.

09/30/2025

Trauma market 𝗧𝗢𝗣𝗦 $𝟵𝗕 𝗶𝗻 𝟮𝟬𝟮𝟰: What’s next for 2025?

A few things stood out in the recent ORTHOWORLD Inc. article on the trauma market:

👉 Global trauma sales crossed US$9 billion in 2024. Projections point to US$9.4B in 2025, and growing further to ~US$10.7B by 2028.

👉 Foot & ankle remains one of the most-watched segments. The segment (worth over US$5B across its sub‐areas) is still attractive for M&A and innovation.

Big M&A moves are reshaping portfolios in this space. Zimmer Biomet’s acquisition of Paragon 28 (US$1.2B) has significantly boosted its foot & ankle presence.

👉 Core trauma is having a moment. Less elective, more essential, innovation (both in product design and support programs) plus, focused strategy, are helping companies like Stryker scale in this space.

👉 Smaller players are carving out leadership in niche segments (for example, OrthoPediatrics).

Read the full article here ▶️ https://bit.ly/4mQWXYA

A look at the current state of the foot and ankle market, the growth of core trauma and ways that smaller players are leveraging niche subsegments.

09/26/2025

Enhatch just made TIME's list of the Top 25 Companies of 2025!

Being recognized by TIME in the & category is a tremendous honor.

Every day, our team works to harness the power of intelligence and advanced to help medical device companies scale solutions more .

To us, this recognition is a reminder that the work that we do creates real impact for patients, surgeons, medical device companies and the entire healthcare ecosystem.

Thank you to you to everone who believed in our mission: our amazing team, investors, partners and supporters! We could not have done this without you.

Here's to continuing to push forward, together.

Link to the article 👉

TIME and Statista have named 400 companies pushing health forward

09/23/2025

A 2025 report by Precedence Research indicates that the global foot and ankle devices market is on a steady climb.

It is projected to grow from $𝟱.𝟰𝟮𝗕 𝗶𝗻 𝟮𝟬𝟮𝟱 𝘁𝗼 𝗻𝗲𝗮𝗿𝗹𝘆 $𝟵.𝟵𝗕 𝗯𝘆 𝟮𝟬𝟯𝟰 𝗮𝘁 𝗮 𝗖𝗔𝗚𝗥 𝗼𝗳 𝟲.𝟵𝟰%.

North America, led by the U.S., holds the largest share, with the U.S. market alone valued at $1.75B in 2024 and expected to double by 2034.

What’s driving this growth?

📌 An aging population.

📌 Rising sports and trauma injuries.

📌 Increasing cases of diabetes and osteoarthritis.

📌 Adoption of advanced surgical technologies, including patient-specific solutions.

While most market data groups all advanced foot & ankle devices together, demand for personalized implants is clearly growing.

With innovations like 3D printing, robotic surgery, and minimally invasive techniques, surgeons have more tools than ever to improve fit, precision, and recovery times.

At Enhatch, we’re excited about how technology can make foot and ankle care more accurate, efficient, and personalized — helping patients get back on their feet faster.

Link to research report 👉 https://bit.ly/46haiEm

09/18/2025

is rewriting the map in , literally!

An article published in Medical Design & Outsourcing mentions researchers at Oregon Health & Science University (OHSU) that have launched an AI-powered tool that makes tumor mapping sharper, faster, and more scalable.

Scientists can now spot subtle changes in cancer tissues and track how therapies affect different cell populations, all while using data from much larger patient groups.

AI in healthcare is bringing the power to pinpoint, personalize, and ultimately improve how we fight disease.

Researchers at Oregon Health & Science University’s Knight Cancer Institute have developed a machine-learning tool that uses standard bulk sequencing data to estimate the mix of cell types in tumor tissue.

09/16/2025

How is shaping the future of ?

Hear what our Director of R&D, Kevin Sichler, has to say.

"𝘛𝘩𝘦 𝘳𝘦𝘢𝘭 𝘱𝘰𝘸𝘦𝘳 𝘰𝘧 𝘈𝘐 𝘪𝘯 𝘮𝘦𝘥𝘵𝘦𝘤𝘩? 𝘐𝘵 𝘢𝘮𝘱𝘭𝘪𝘧𝘪𝘦𝘴 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘨𝘳𝘦𝘢𝘵 𝘪𝘥𝘦𝘢𝘴. 𝘊𝘰𝘮𝘣𝘪𝘯𝘦 𝘈𝘐 𝘸𝘪𝘵𝘩 𝘥𝘦𝘦𝘱 𝘙&𝘋 𝘦𝘹𝘱𝘦𝘳𝘵𝘪𝘴𝘦, 𝘺𝘰𝘶 𝘤𝘳𝘦𝘢𝘵𝘦 𝘴𝘰𝘭𝘶𝘵𝘪𝘰𝘯𝘴 𝘵𝘩𝘢𝘵 𝘴𝘵𝘳𝘦𝘢𝘮𝘭𝘪𝘯𝘦 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵, 𝘪𝘮𝘱𝘳𝘰𝘷𝘦 𝘱𝘳𝘦𝘤𝘪𝘴𝘪𝘰𝘯, 𝘢𝘯𝘥 𝘣𝘳𝘪𝘯𝘨 𝘣𝘦𝘵𝘵𝘦𝘳 𝘴𝘰𝘭𝘶𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘮𝘢𝘳𝘬𝘦𝘵 𝘧𝘢𝘴𝘵𝘦𝘳. 𝘍𝘰𝘳 𝘦𝘹𝘢𝘮𝘱𝘭𝘦, 𝘢𝘵 Enhatch, 𝘸𝘦 𝘢𝘳𝘦 𝘶𝘴𝘪𝘯𝘨 𝘈𝘐 𝘵𝘰 𝘴𝘵𝘳𝘦𝘢𝘮𝘭𝘪𝘯𝘦 𝘢𝘯𝘥 𝘥𝘳𝘪𝘷𝘦 𝘦𝘧𝘧𝘪𝘤𝘪𝘦𝘯𝘤𝘺 𝘪𝘯 𝘱𝘳𝘦𝘰𝘱𝘦𝘳𝘢𝘵𝘪𝘷𝘦 𝘱𝘭𝘢𝘯𝘯𝘪𝘯𝘨 𝘧𝘰𝘳 𝘱𝘢𝘵𝘪𝘦𝘯𝘵-𝘴𝘱𝘦𝘤𝘪𝘧𝘪𝘤 𝘴𝘰𝘭𝘶𝘵𝘪𝘰𝘯𝘴. 𝘐𝘵'𝘴 𝘢𝘣𝘰𝘶𝘵 𝘨𝘪𝘷𝘪𝘯𝘨 𝘵𝘦𝘢𝘮𝘴 𝘤𝘶𝘵𝘵𝘪𝘯𝘨-𝘦𝘥𝘨𝘦 3𝘋 𝘱𝘭𝘢𝘯𝘯𝘪𝘯𝘨 𝘴𝘰𝘭𝘶𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘮𝘰𝘷𝘦 𝘸𝘪𝘵𝘩 𝘴𝘱𝘦𝘦𝘥 𝘢𝘯𝘥 𝘢𝘤𝘤𝘶𝘳𝘢𝘤𝘺."

&D

09/09/2025

Is your explainable enough for the FDA?

The FDA isn’t just reviewing what your AI does. They want to know how it works.

In her latest article, Monica Williams, RA/QA Manager at Enhatch, breaks down why AI explainability is a must-have for FDA clearance and explains how medtech companies can meet regulatory expectations.

She shares common pitfalls to avoid and practical tips from our own 510(k) experience.

If you’re building an AI-enabled medical device, this is a must-read.

Read the full blog here 👉 https://bit.ly/4m2KrVd

AI explainability is critical for FDA clearance of AI/ML-enabled medical devices. Learn how medtech companies can meet regulatory expectations during submissions.

09/04/2025

𝗦𝘁𝗿𝘂𝗴𝗴𝗹𝗶𝗻𝗴 𝘁𝗼 𝗶𝗱𝗲𝗻𝘁𝗶𝗳𝘆 𝗶𝗺𝗽𝗹𝗮𝗻𝘁𝘀 𝗯𝗲𝗳𝗼𝗿𝗲 𝗮 𝗿𝗲𝘃𝗶𝘀𝗶𝗼𝗻? AI may have the answer!

One of the promising applications of AI in orthopedics is identifying previously implanted devices before a revision procedure.

According to the article "𝗧𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗔𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗜𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲 𝗶𝗻 𝗢𝗿𝘁𝗵𝗼𝗽𝗲𝗱𝗶𝗰𝘀" on OrthoFeed a recent study published in Arthroplasty showed that a deep learning model was able to predict the type of knee implant with 99% accuracy.

This level of precision can save valuable time during pre-op planning and improve efficiency during surgery.

Here is the link to the article 👉 https://bit.ly/3JJxJgJ

(ODT) – By now, everyone with access to the news has seen some impact of artificial intelligence (AI) and machine learning (ML) on the world. Everything from legal briefs to pop hits is being…

09/01/2025

Happy Labor Day! 👨‍🍳 👩‍🏫 👩‍🏭 👨‍🚒 👩‍💻 👨‍💼

A big special thank you to our amazing team, partners, and everyone in the medtech community whose dedication and hard work make better patient care possible every day.

From the engineers designing smarter solutions to the surgical teams delivering exceptional care, your commitment inspires us every day.

Wishing everyone a safe and relaxing holiday.